General exclusions: • Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months; • Patients who have been in a skilled nursing facility in the last 3 months • Patient or provider feedback indicating allergy or intolerance to the drug in the past • Patient or provider feedback indicating that there is a contraindication to adding the drug
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
Public Comments